BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 24626739)

  • 21. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
    Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
    Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells].
    Xiao YS; Zhou J; Fan J; Sun QM; Zhao Y; Sun RX; Liu YK; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):444-7. PubMed ID: 19024520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.
    Sun Y; Qiao L; Xia HH; Lin MC; Zou B; Yuan Y; Zhu S; Gu Q; Cheung TK; Kung HF; Yuen MF; Chan AO; Wong BC
    Cancer Lett; 2008 Feb; 260(1-2):62-71. PubMed ID: 18035482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells.
    Zhang P; Jiang G; Gao J; Li L; Du J; Jiao X
    Oncol Rep; 2013 Jan; 29(1):269-75. PubMed ID: 23042548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of SSX2 gene in human urologic neoplasms].
    Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis delta virus inhibits alpha interferon signaling.
    Pugnale P; Pazienza V; Guilloux K; Negro F
    Hepatology; 2009 Feb; 49(2):398-406. PubMed ID: 19085955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
    Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Zimmerman O; Olbrich P; Freeman AF; Rosen LB; Uzel G; Zerbe CS; Rosenzweig SD; Kuehn HS; Holmes KL; Stephany D; Ding L; Sampaio EP; Hsu AP; Holland SM
    Front Immunol; 2019; 10():1433. PubMed ID: 31354696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of stat91, ras-independent signal transducer and activator, in human gastric carcinomas.
    Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Fujii K; Hisatsugu T; Tahara E
    Int J Oncol; 1995 Oct; 7(4):907-11. PubMed ID: 21552922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1/2 inhibition.
    Beaufils C; Fernandez I; Marchitto L; Morin MP; De Bruycker JJ; Cellot S; Soucy JF; Ovetchkine P; Oligny L; Haddad E; Touzot F
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3838-3840.e1. PubMed ID: 34217848
    [No Abstract]   [Full Text] [Related]  

  • 32. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
    Ma H; Jin S; Yang W; Zhou G; Zhao M; Fang S; Zhang Z; Hu J
    Br J Cancer; 2018 Feb; 118(4):509-521. PubMed ID: 29348488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of interferon-α signaling by hepatitis E virus.
    Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
    Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
    Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
    J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.
    Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM
    Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated signal transducer and activator of transcription 1 is a potential predictor of interferon response in patients with advanced renal cell carcinoma.
    Li W; Wei Q; Liang J
    Mol Med Rep; 2014 May; 9(5):1929-34. PubMed ID: 24626739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.
    Shang D; Liu Y; Ito N; Kamoto T; Ogawa O
    Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.